ADAP

Adaptimmune Therapeutics
ADAP

Overview Fund Activity

40 hedge funds and large institutions have $121M invested in Adaptimmune Therapeutics in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 11 closing their positions.

Holders
40
Holders Change
-6
Holders Change %
-13.04%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
10
Reduced
10
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VIA
1
Vident Investment Advisory
Georgia
$785K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$1.8M
3
AFM
3
Anson Funds Management
Texas
$418K
4
AG
4
Artal Group
Luxembourg
$1.22M
5
IBT
5
International Biotechnology Trust
United Kingdom
$387K

Top Sellers

1
PI
1
Putnam Investments
Massachusetts
$0
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$2.16M
3
IHM
3
Iguana Healthcare Management
New York
$405K
4
RG
4
Rathbones Group
United Kingdom
$812K
5
Capital World Investors
5
Capital World Investors
California
$18.1M
Name Market Value Shares Shares
Change 		Shares
Change %
NMC
1
NEA Management Company
Maryland
$40M 9,880,999 – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$28.6M 7,065,180 – –
Capital World Investors
3
Capital World Investors
California
$18.1M 4,480,486 -120,514 -3%
Baillie Gifford & Co
4
Baillie Gifford & Co
United Kingdom
$3.73M 920,984 – –
Fidelity International
5
Fidelity International
Bermuda
$3.05M 753,741 +1 +0%
O
6
OrbiMed
New York
$2.93M 724,184 – –
RSCM
7
Rock Springs Capital Management
Maryland
$2.73M 675,000 – –
Millennium Management
8
Millennium Management
New York
$2.72M 671,660 +25,170 +4%
QF
9
QVT Financial
New York
$2.66M 657,258 -64,975 -9%
TCM
10
Tekla Capital Management
Massachusetts
$2.29M 566,368 – –
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$2.16M 533,901 -623,148 -54%
Wellington Management Group
12
Wellington Management Group
Massachusetts
$2.1M 518,523 -55,200 -10%
Renaissance Technologies
13
Renaissance Technologies
New York
$1.8M 445,100 +116,400 +35%
AG
14
Artal Group
Luxembourg
$1.22M 300,000 +100,000 +50%
A
15
Abingworth
United Kingdom
$1M 250,000 – –
RG
16
Rathbones Group
United Kingdom
$812K 200,525 -129,600 -39%
VIA
17
Vident Investment Advisory
Georgia
$785K 193,869 +120,724 +165%
WMSA
18
Weiss Multi-Strategy Advisers
New York
$446K 110,000 +46,000 +72%
AFM
19
Anson Funds Management
Texas
$418K 103,282 +103,282 New
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$407K 100,523 +18,216 +22%
IHM
21
Iguana Healthcare Management
New York
$405K 100,000 -200,000 -67%
BBA
22
Baker Bros. Advisors
New York
$405K 100,000 – –
IBT
23
International Biotechnology Trust
United Kingdom
$387K 96,419 +96,419 New
AA
24
ALPS Advisors
Colorado
$275K 68,024 +68,024 New
State Street
25
State Street
Massachusetts
$266K 65,800 – –
1
2 3